California State Teachers Retirement System Has $1.92 Billion Stock Position in DaVita Inc. $DVA

California State Teachers Retirement System lifted its holdings in shares of DaVita Inc. (NYSE:DVA - Free Report) by 18,932.5% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 8,610,866 shares of the company's stock after purchasing an additional 8,565,623 shares during the period. California State Teachers Retirement System owned 13.50% of DaVita worth $1,915,745,000 as of its most recent filing with the SEC.

Several other institutional investors also recently modified their holdings of the business. Value Investment Professionals LLC boosted its position in DaVita by 2.0% during the second quarter. Value Investment Professionals LLC now owns 2,501 shares of the company's stock valued at $556,000 after acquiring an additional 50 shares during the last quarter. Kesler Norman & Wride LLC lifted its position in shares of DaVita by 0.8% during the 1st quarter. Kesler Norman & Wride LLC now owns 6,816 shares of the company's stock valued at $1,048,000 after acquiring an additional 55 shares during the period. Northwestern Mutual Wealth Management Co. boosted its stake in DaVita by 4.1% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,915 shares of the company's stock worth $426,000 after acquiring an additional 76 shares in the last quarter. Gen Wealth Partners Inc boosted its stake in DaVita by 10.0% during the fourth quarter. Gen Wealth Partners Inc now owns 880 shares of the company's stock worth $100,000 after acquiring an additional 80 shares in the last quarter. Finally, NewEdge Advisors LLC grew its holdings in DaVita by 20.8% in the first quarter. NewEdge Advisors LLC now owns 511 shares of the company's stock worth $78,000 after purchasing an additional 88 shares during the period. Institutional investors own 90.12% of the company's stock.

Insider Transactions at DaVita

In related news, insider Kathleen Waters sold 15,405 shares of the business's stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $208.40, for a total transaction of $3,210,402.00. Following the transaction, the insider owned 109,194 shares in the company, valued at $22,756,029.60. The trade was a 12.36% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.90% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the company. Deutsche Bank Aktiengesellschaft restated a "buy" rating and set a $265.00 price objective on shares of DaVita in a report on Wednesday, August 5th. TD Cowen raised DaVita from a "hold" rating to a "buy" rating and boosted their price objective for the stock from $201.00 to $220.00 in a report on Friday, August 7th. Raymond James Financial set a $220.00 price objective on DaVita in a research note on Friday, August 7th. UBS Group raised their target price on DaVita from $235.00 to $270.00 and gave the company a "buy" rating in a report on Friday, July 10th. Finally, Weiss Ratings upgraded shares of DaVita from a "hold (c+)" rating to a "buy (b-)" rating in a report on Wednesday, August 5th. Four analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, DaVita has an average rating of "Moderate Buy" and an average price target of $233.43.

DaVita Trading Up 0.1%

NYSE DVA opened at $181.56 on Friday. The firm has a market cap of $11.58 billion, a PE ratio of 14.86, a price-to-earnings-growth ratio of 0.47 and a beta of 0.83. DaVita Inc. has a 1-year low of $101.00 and a 1-year high of $247.49. The stock has a 50-day moving average of $204.02 and a 200-day moving average of $185.43.

DaVita (NYSE:DVA - Get Free Report) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $4.02 EPS for the quarter, topping analysts' consensus estimates of $3.88 by $0.14. The business had revenue of $3.55 billion for the quarter, compared to analysts' expectations of $3.50 billion. DaVita had a negative return on equity of 217.63% and a net margin of 6.05%.The business's quarterly revenue was up 5.2% on a year-over-year basis. During the same period in the previous year, the firm earned $2.95 EPS. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. As a group, equities research analysts forecast that DaVita Inc. will post 14.57 earnings per share for the current fiscal year.

DaVita Profile

DaVita Inc NYSE: DVA is a healthcare company focused primarily on kidney care. Through its DaVita Kidney Care business, the company provides outpatient dialysis services for people with chronic kidney failure, including in-center hemodialysis and home-based dialysis options. Its services also include clinical care, education, nutrition support and other resources intended to help patients manage kidney disease.

DaVita also provides broader kidney-care services, including chronic kidney disease management, care coordination and support for patients who may be candidates for kidney transplantation.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.